医学
2型糖尿病
安慰剂
利西塞纳泰德
内科学
2型糖尿病
胰高血糖素样肽-1
荟萃分析
糖尿病
不利影响
随机对照试验
心脏病学
重症监护医学
艾塞那肽
内分泌学
病理
替代医学
作者
Frederick Berro Rivera,Linnaeus Louisse A. Cruz,John Vincent Magalong,Jade Monica Marie Ruyeras,John Paul Aparece,Nathan Ross B. Bantayan,Kyla Lara-Breitinger,Martha Gulati
标识
DOI:10.1016/j.ajpc.2024.100679
摘要
Significant reductions in MACE, overall and CV mortality, stroke, coronary revascularization, and composite kidney outcome with GLP-1RA treatment were noted across all subgroups.
科研通智能强力驱动
Strongly Powered by AbleSci AI